A Richey Sharrett Selected Research

Fructosamine

1/2019	The Association of Late-Life Diabetes Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia: The ARIC Study.
1/2018	Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
4/2016	Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia.
4/2014	Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Richey Sharrett Research Topics

Disease

92	Atherosclerosis 01/2021 - 01/2002
38	Hypertension (High Blood Pressure) 10/2022 - 03/2002
27	Dementia (Dementias) 10/2022 - 07/2014
26	Coronary Disease (Coronary Heart Disease) 10/2022 - 01/2002
24	Stroke (Strokes) 01/2021 - 01/2002
21	Cardiovascular Diseases (Cardiovascular Disease) 10/2016 - 01/2002
16	Cognitive Dysfunction 01/2021 - 06/2002
11	Inflammation (Inflammations) 11/2012 - 01/2002
8	Peripheral Arterial Disease 01/2020 - 01/2002
8	Carotid Artery Diseases 05/2013 - 04/2005
7	Carotid Stenosis (Carotid Artery Stenosis) 01/2021 - 04/2003
7	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020 - 01/2006
7	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2011 - 07/2002
6	Ischemic Stroke 03/2022 - 03/2003
6	Lacunar Stroke 01/2022 - 07/2007
6	Hemorrhage 01/2020 - 07/2002
6	Diabetes Mellitus 09/2019 - 05/2002
6	Microaneurysm 07/2010 - 07/2002
5	Chronic Renal Insufficiency 01/2020 - 09/2004
5	Hyperglycemia 01/2019 - 10/2002
5	Obesity 10/2017 - 10/2002
4	Prediabetic State (Prediabetes) 01/2021 - 10/2014
4	Myocardial Infarction 10/2014 - 03/2002
3	Cerebral Infarction 01/2021 - 01/2006
3	Vascular Diseases (Vascular Disease) 01/2020 - 03/2002
3	Heart Failure 01/2020 - 06/2011
3	Orthostatic Hypotension (Postural Hypotension) 01/2018 - 08/2006
3	Infarction (Infarctions) 11/2017 - 12/2002
3	Insulin Resistance 07/2014 - 09/2011
3	HIV Infections (HIV Infection) 10/2010 - 01/2006
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2008 - 07/2002
2	Pathologic Constriction (Stenosis) 01/2021 - 05/2011
2	Chronic Limb-Threatening Ischemia 01/2020 - 01/2018
2	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 12/2017
2	Frailty 01/2020 - 01/2019
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 11/2017
2	Prehypertension 10/2017 - 10/2014
2	Hyperlipidemias (Hyperlipidemia) 01/2017 - 08/2015
2	Chronic Kidney Failure (Chronic Renal Failure) 04/2016 - 01/2011
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 09/2015 - 05/2003
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2014 - 09/2004
2	Brain Infarction 07/2014 - 07/2010
2	Disease Progression 04/2014 - 01/2006
2	Atherosclerotic Plaque (Atheroma) 12/2011 - 02/2008
2	Abdominal Obesity 09/2011 - 09/2004
2	Acquired Immunodeficiency Syndrome (AIDS) 10/2010 - 01/2006
2	Cerebral Small Vessel Diseases 07/2010 - 07/2010
2	Macular Degeneration (Age-Related Maculopathy) 10/2008 - 02/2006

Drug/Important Bio-Agent (IBA)

53	Retinaldehyde (Retinal)IBA 01/2022 - 03/2002
16	LipidsIBA 01/2021 - 03/2002
15	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2005
14	ApolipoproteinsIBA 10/2022 - 03/2002
13	CholesterolIBA 01/2018 - 03/2003
12	LDL CholesterolIBA 01/2018 - 03/2002
12	HDL CholesterolIBA 07/2014 - 10/2002
11	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2006
10	C-Reactive ProteinIBA 10/2022 - 02/2004
9	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 04/2003
9	Triglycerides (Triacylglycerol)IBA 01/2018 - 03/2002
9	oxidized low density lipoproteinIBA 05/2013 - 02/2004
8	Apolipoproteins E (ApoE)IBA 10/2022 - 03/2002
8	Amyloid (Amyloid Fibrils)IBA 10/2022 - 08/2016
8	Troponin T (Troponin T1)IBA 01/2018 - 06/2011
7	hydroxide ionIBA 10/2019 - 08/2006
6	AlbuminsIBA 10/2022 - 04/2014
6	Hemoglobins (Hemoglobin)IBA 01/2018 - 01/2006
6	CalciumIBA 05/2017 - 04/2007
5	florbetapirIBA 10/2022 - 08/2016
5	1,5-anhydroglucitolIBA 01/2019 - 10/2016
5	HDL LipoproteinsIBA 12/2011 - 03/2002
4	FructosamineIBA 01/2019 - 04/2014
4	Lipoproteins (Lipoprotein)IBA 01/2017 - 03/2003
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2016 - 02/2012
4	LDL Lipoproteins (beta Lipoproteins)IBA 12/2011 - 03/2002
4	Fibrinogen (Factor I)FDA Link 01/2008 - 05/2002
3	CreatinineIBA 10/2022 - 09/2004
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020 - 01/2016
3	Vitamin D FDA LinkGeneric 10/2019 - 07/2014
3	25-hydroxyvitamin DIBA 01/2018 - 04/2012
3	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 08/2015 - 02/2004
3	Apolipoproteins B (ApoB)IBA 07/2014 - 12/2011
3	lipoprotein cholesterolIBA 07/2014 - 12/2011
3	CadmiumIBA 09/2010 - 06/2004
3	Interleukin-6 (Interleukin 6)IBA 10/2008 - 12/2002
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 01/2011
2	Insulin (Novolin)FDA Link 01/2021 - 02/2007
2	TroponinIBA 01/2020 - 01/2018
2	pro-brain natriuretic peptide (1-76)IBA 01/2018 - 01/2016
2	Apolipoproteins AIBA 07/2014 - 12/2011
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 07/2014 - 12/2011
2	Lipoprotein(a)IBA 01/2012 - 04/2005
2	ArsenicIBA 03/2011 - 12/2005
2	AntibodiesIBA 10/2009 - 07/2006
2	Cholesterol Ester Transfer ProteinsIBA 03/2009 - 10/2008
2	ORALIT (ORS)IBA 02/2008 - 06/2004
2	InterleukinsIBA 06/2006 - 12/2002

Therapy/Procedure

3	Glycemic Control 01/2019 - 04/2008
2	Surgical Amputation (Amputations) 01/2020 - 01/2018
2	Highly Active Antiretroviral Therapy (HAART) 10/2010 - 10/2007
2	Therapeutics 04/2009 - 12/2005